Structure-activity studies of new melanocortin peptides containing an aromatic amino acid at the N-terminal position

Paolo Grieco, Minying Cai, Alexander V. Mayorov, Dev Trivedi, Victor J Hruby

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Cyclic melanotropin peptides, designed with an aromatic amino acid substitution at the N-terminal position of the MT-II-type scaffold, were prepared by solid-phase peptide synthesis and evaluated for their ability to bind to and activate human melanocortin-1, -3, -4, and -5 receptors. The structure-activity studies of these MT-II analogues have identified a selective antagonist at the hMC4R (H-Phe-c[Asp-Pro-d-Nal(2′)-Arg-Trp-Gly-Lys]- NH2, pA2 = 8.7), a selective partial agonist at the hMC4R (H-d-Nal(2′)-c[Asp-Pro-d-Phe-Arg-Trp-Gly-Lys]-NH2, IC 50 = 11 nM, EC50 = 56 nM), and a selective partial agonist at the hMC3R (H-d-Phe-c[Asp-Pro-d-Phe-Arg-Trp-Lys]-NH2, IC 50 = 3.7 nM, EC50 = 4.9 nM). Aromatic amino acid substitution at the N-terminus in conjuction with the expansion of the 23-membered cyclic lactam MT-II scaffold to a 26-membered scaffold by addition of a Gly residue in position 10 leads to melanotropin peptides with enhanced receptor selectivity.

Original languageEnglish (US)
Pages (from-to)472-481
Number of pages10
JournalPeptides
Volume27
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

aspartyl-proline
Melanocortins
Aromatic Amino Acids
Scaffolds
Melanocyte-Stimulating Hormones
Amino Acid Substitution
Peptides
Substitution reactions
Dilatation and Curettage
Lactams
Cyclic Peptides
Solid-Phase Synthesis Techniques
GW-amide

Keywords

  • Cyclic peptide lactams
  • Melanotropin receptors
  • Melanotropins
  • N-Terminal aromatic amino acid substitution
  • Receptor selectivity
  • Structure-activity

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Structure-activity studies of new melanocortin peptides containing an aromatic amino acid at the N-terminal position. / Grieco, Paolo; Cai, Minying; Mayorov, Alexander V.; Trivedi, Dev; Hruby, Victor J.

In: Peptides, Vol. 27, No. 2, 02.2006, p. 472-481.

Research output: Contribution to journalArticle

@article{9d7d0eb4b40e4c8da19a9effc9964a9d,
title = "Structure-activity studies of new melanocortin peptides containing an aromatic amino acid at the N-terminal position",
abstract = "Cyclic melanotropin peptides, designed with an aromatic amino acid substitution at the N-terminal position of the MT-II-type scaffold, were prepared by solid-phase peptide synthesis and evaluated for their ability to bind to and activate human melanocortin-1, -3, -4, and -5 receptors. The structure-activity studies of these MT-II analogues have identified a selective antagonist at the hMC4R (H-Phe-c[Asp-Pro-d-Nal(2′)-Arg-Trp-Gly-Lys]- NH2, pA2 = 8.7), a selective partial agonist at the hMC4R (H-d-Nal(2′)-c[Asp-Pro-d-Phe-Arg-Trp-Gly-Lys]-NH2, IC 50 = 11 nM, EC50 = 56 nM), and a selective partial agonist at the hMC3R (H-d-Phe-c[Asp-Pro-d-Phe-Arg-Trp-Lys]-NH2, IC 50 = 3.7 nM, EC50 = 4.9 nM). Aromatic amino acid substitution at the N-terminus in conjuction with the expansion of the 23-membered cyclic lactam MT-II scaffold to a 26-membered scaffold by addition of a Gly residue in position 10 leads to melanotropin peptides with enhanced receptor selectivity.",
keywords = "Cyclic peptide lactams, Melanotropin receptors, Melanotropins, N-Terminal aromatic amino acid substitution, Receptor selectivity, Structure-activity",
author = "Paolo Grieco and Minying Cai and Mayorov, {Alexander V.} and Dev Trivedi and Hruby, {Victor J}",
year = "2006",
month = "2",
doi = "10.1016/j.peptides.2005.01.032",
language = "English (US)",
volume = "27",
pages = "472--481",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Structure-activity studies of new melanocortin peptides containing an aromatic amino acid at the N-terminal position

AU - Grieco, Paolo

AU - Cai, Minying

AU - Mayorov, Alexander V.

AU - Trivedi, Dev

AU - Hruby, Victor J

PY - 2006/2

Y1 - 2006/2

N2 - Cyclic melanotropin peptides, designed with an aromatic amino acid substitution at the N-terminal position of the MT-II-type scaffold, were prepared by solid-phase peptide synthesis and evaluated for their ability to bind to and activate human melanocortin-1, -3, -4, and -5 receptors. The structure-activity studies of these MT-II analogues have identified a selective antagonist at the hMC4R (H-Phe-c[Asp-Pro-d-Nal(2′)-Arg-Trp-Gly-Lys]- NH2, pA2 = 8.7), a selective partial agonist at the hMC4R (H-d-Nal(2′)-c[Asp-Pro-d-Phe-Arg-Trp-Gly-Lys]-NH2, IC 50 = 11 nM, EC50 = 56 nM), and a selective partial agonist at the hMC3R (H-d-Phe-c[Asp-Pro-d-Phe-Arg-Trp-Lys]-NH2, IC 50 = 3.7 nM, EC50 = 4.9 nM). Aromatic amino acid substitution at the N-terminus in conjuction with the expansion of the 23-membered cyclic lactam MT-II scaffold to a 26-membered scaffold by addition of a Gly residue in position 10 leads to melanotropin peptides with enhanced receptor selectivity.

AB - Cyclic melanotropin peptides, designed with an aromatic amino acid substitution at the N-terminal position of the MT-II-type scaffold, were prepared by solid-phase peptide synthesis and evaluated for their ability to bind to and activate human melanocortin-1, -3, -4, and -5 receptors. The structure-activity studies of these MT-II analogues have identified a selective antagonist at the hMC4R (H-Phe-c[Asp-Pro-d-Nal(2′)-Arg-Trp-Gly-Lys]- NH2, pA2 = 8.7), a selective partial agonist at the hMC4R (H-d-Nal(2′)-c[Asp-Pro-d-Phe-Arg-Trp-Gly-Lys]-NH2, IC 50 = 11 nM, EC50 = 56 nM), and a selective partial agonist at the hMC3R (H-d-Phe-c[Asp-Pro-d-Phe-Arg-Trp-Lys]-NH2, IC 50 = 3.7 nM, EC50 = 4.9 nM). Aromatic amino acid substitution at the N-terminus in conjuction with the expansion of the 23-membered cyclic lactam MT-II scaffold to a 26-membered scaffold by addition of a Gly residue in position 10 leads to melanotropin peptides with enhanced receptor selectivity.

KW - Cyclic peptide lactams

KW - Melanotropin receptors

KW - Melanotropins

KW - N-Terminal aromatic amino acid substitution

KW - Receptor selectivity

KW - Structure-activity

UR - http://www.scopus.com/inward/record.url?scp=31544439367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31544439367&partnerID=8YFLogxK

U2 - 10.1016/j.peptides.2005.01.032

DO - 10.1016/j.peptides.2005.01.032

M3 - Article

VL - 27

SP - 472

EP - 481

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 2

ER -